Tivic Health Systems Inc Share Price & Technical Analysis
TIVC · $1.40
Healthcare / Medical Devices
$1.40
Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offer…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-10% return in May, -31% avg return in past 3 year May month.
-34% return in 2026, -111% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -20% | -27% | 13% | 11% | -10% | – | – | – | – | – | – | – | -34% |
| 25 | -26% | 51% | -59% | 76% | -7% | 2% | -12% | -11% | -3% | -14% | -28% | -21% | -53% |
| 24 | -28% | 36% | -30% | -16% | -61% | -6% | 42% | -40% | -26% | 17% | -12% | 37% | -86% |
| 23 | 24% | -76% | -21% | -2% | -24% | 3% | -52% | -48% | -28% | -30% | 78% | -17% | -193% |
| 22 | -57% | -18% | 18% | -4% | 13% | 10% | 15% | -14% | -24% | 5% | -15% | -54% | -126% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Downtrend · Strong
Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$4.03M
P/E ratio
—
52W high
$5.60
52W low
$0.72
Volume
2,63,294
Beta
1.84
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Tivic Health Systems Inc share price today?
- Tivic Health Systems Inc (TIVC) last traded around $1.40 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TIVC have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TIVC. Download the app for real-time alerts.
- How can I analyze Tivic Health Systems Inc stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.